Alerts will be sent to your verified email
Verify EmailWELCURE
|
Welcure Drugs&Pharma
|
Roni Households
|
Anmol India
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
58.66 % | -2.41 % | 20.37 % |
|
5yr average Equity Multiplier
|
-0.69 | 2.33 | 4.17 |
|
5yr Average Asset Turnover Ratio
|
0.59 | 0.56 | 3.99 |
|
5yr Avg Net Profit Margin
|
-73.67 % | -0.74 % | 1.23 % |
|
Price to Book
|
0.82 | 5.06 | 0.79 |
|
P/E
|
2.99 | 128.69 | 9.77 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 377.84 Days | 30.36 Days |
|
Inventory Days
|
20.66 Days | 143.96 Days | 27.52 Days |
|
Days Receivable
|
1232.42 Days | 339.45 Days | 18.26 Days |
|
Days Payable
|
0.0 | 249.67 Days | -20.24 Days |
|
5yr Average Interest Coverage Ratio
|
-2.67 | 2.6 | 3.64 |
|
5yr Avg ROCE
|
8.46 % | 1.67 % | 26.2 % |
|
5yr Avg Operating Profit Margin
|
-73.54 % | 5.35 % | 1.78 % |
|
5 yr average Debt to Equity
|
-0.59 | 0.46 | 2.16 |
|
5yr CAGR Net Profit
|
-2.01 % | n/a | -6.86 % |
|
5yr Average Return on Assets
|
13.61 % | 0.18 % | 5.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 60.11 % | 50.2 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 38.28 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -5.29 % | -6.88 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Welcure Drugs&Pharma
|
Roni Households
|
Anmol India
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|